Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Malignant Mesothelioma Therapeutics Market Outlook
The global malignant mesothelioma therapeutics market is projected to grow at a CAGR of 7.5% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rising awareness regarding the treatment of mesothelioma and the availability of advanced therapeutics procedures is expected to aid the industry over the forecast period. Further, the use of asbestos in various products and sectors, which is a major cause for the development of mesothelioma, is expected to drive the global market for malignant mesothelioma therapeutic.
Market Segmentation
Malignant mesothelioma is a tumour that develops in the linings of the lungs, stomach, or heart due to exposure to or inhalation of asbestos. The treatment of mesothelioma can improve the patient’s quality of life and offers enhanced life expectancy. The global malignant mesothelioma therapeutics market can be divided based on segments like product and application.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is divided based on its product as chemotherapy and other therapeutics.
The industry can be broadly categorised based on its application into:
- Hospital Pharmacies
- Retail Pharmacies
- Oncology Centres
- Other
The EMR report looks into the regional malignant mesothelioma therapeutics markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Market Analysis
The growing incidence of malignant mesothelioma among individuals, globally, is driving the industry for malignant mesothelioma therapeutics. One of the main trends in the market is the growing consciousness regarding malignant mesothelioma among individuals owing to efforts of various organisations conducting awareness programmes about cancer and cancer-causing agents such as asbestos, and their effective treatment. A number of screening programs are being conducted for people who are regularly exposed to asbestos, which finds application in building materials, machines, and transport vehicles in the form of hydrated silicates and long thin fibres, to prevent the disease from progressing to advanced stages. Further, the manufacturers and major players in the industry are focusing on the development of novel therapies with fewer side effects and elevated efficacy, which is expected to aid the industry over the forecast period further.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global malignant mesothelioma therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Bristol-Myers Squibb Co. (NYSE: BMY)
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Pfizer Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global malignant mesothelioma therapeutics market is projected to grow at a CAGR of 7.5% between 2024 and 2032.
The major drivers include the increasing cases of malignant mesothelioma, the increasing awareness regarding cancer treatment, the growing utilisation of asbestos in various sectors, and growing technological advancements.
The growing investments in the development of novel therapies to treat mesothelioma are key trends guiding the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Chemotherapy and other therapeutics are the significant products of malignant mesothelioma therapeutics.
The major applications of the product include hospital pharmacies, retail pharmacies, and oncology centres, among others.
The key market players include Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck and Co., Inc., and Pfizer Inc., among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124